You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Thousands of blood cancer patients could benefit from new drug combination
- 2. Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer
- 3. Clarity enters a Commercial Manufacturing Agreement for Cu-64 SAR-bisPSMA with SpectronRx
- 4. Diagnostic value of [18F]PSMA-1007 PET/CT based on PRIMARY score combined with mpMRI in clinically significant prostate cancer
- 5. Update in the clinical utilization of chemoprevention for breast cancer: a narrative review
- 6. Neutrophil extracellular traps and cannabinoids: potential in cancer metastasis
- 7. Research progress and molecular mechanism of oridonin in the treatment of malignant melanoma
- 8. Effects of gut microbiota in breast cancer
- 9. Abemaciclib treatment patterns and outcome in HR+/HER2- locally advanced or metastatic breast cancer: a real-world study from Kuwait and Lebanon
- 10. Eli Lilly looks beyond its blockbuster obesity drugs with another smart deal
Last updated at 20:47 GMT
Hot News Makers
Health/Pharma Companies
-
48047.73
-
23052.17
-
22038.80
-
19746.90
-
18929.31
-
15299.88
-
12286.15
-
12193.89
-
11918.59
-
10287.94
Drugs, Treatments, Trials
-
18545.30
-
12291.45
-
11555.38
-
6996.96
-
6851.69
-
6267.06
-
5736.01
-
5199.23
-
4476.47
-
3019.69
Last updated at 20:10 GMT
